AU2002210839A1 - Preparation of sodium-hydrogen exchanger type-1 inhibitors - Google Patents
Preparation of sodium-hydrogen exchanger type-1 inhibitorsInfo
- Publication number
- AU2002210839A1 AU2002210839A1 AU2002210839A AU1083902A AU2002210839A1 AU 2002210839 A1 AU2002210839 A1 AU 2002210839A1 AU 2002210839 A AU2002210839 A AU 2002210839A AU 1083902 A AU1083902 A AU 1083902A AU 2002210839 A1 AU2002210839 A1 AU 2002210839A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- sodium
- preparation
- exchanger type
- hydrogen exchanger
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/22—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25335300P | 2000-11-28 | 2000-11-28 | |
| US60253353 | 2000-11-28 | ||
| PCT/IB2001/002052 WO2002044133A1 (en) | 2000-11-28 | 2001-10-31 | Preparation of sodium-hydrogen exchanger type-1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002210839A1 true AU2002210839A1 (en) | 2002-06-11 |
Family
ID=22959914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002210839A Abandoned AU2002210839A1 (en) | 2000-11-28 | 2001-10-31 | Preparation of sodium-hydrogen exchanger type-1 inhibitors |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6753334B2 (es) |
| EP (1) | EP1337508A1 (es) |
| JP (1) | JP2004514706A (es) |
| AR (1) | AR035601A1 (es) |
| AU (1) | AU2002210839A1 (es) |
| BR (1) | BR0115616A (es) |
| CA (1) | CA2430061A1 (es) |
| MX (1) | MXPA03004783A (es) |
| WO (1) | WO2002044133A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1456181A1 (en) | 2001-12-19 | 2004-09-15 | Pfizer Products Inc. | Methods for preparing sodium-hydrogen exchanger type-1 inhibitors |
| BRPI0610459A2 (pt) | 2005-04-05 | 2010-06-22 | Hoffmann La Roche | composto, processo para a sua preparação, composições farmacêuticas que o compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por inibidores de deidrogenase de hidroxiesteróides-11b e utilização do composto |
| CN101164156A (zh) * | 2005-08-05 | 2008-04-16 | 东京毅力科创株式会社 | 基板处理装置和用于该基板处理装置的基板载置台 |
| DK1999114T3 (en) | 2006-03-22 | 2015-08-03 | Hoffmann La Roche | Pyrazoles AS 11-BETA-HSD-1 |
| WO2007114315A1 (ja) * | 2006-03-30 | 2007-10-11 | Santen Pharmaceutical Co., Ltd. | 角結膜障害治療剤 |
| ES2522968T3 (es) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| CN103772282B (zh) * | 2014-02-26 | 2015-09-23 | 上海毕得医药科技有限公司 | 一种3-叔丁基-1h-吡唑-4-甲醛的制备方法 |
| EP3584241B1 (en) | 2017-02-14 | 2023-04-26 | FUJIFILM Corporation | Method for producing indazole compound, and indazole compound |
| JP2021524461A (ja) | 2018-05-24 | 2021-09-13 | バイエル・アクチエンゲゼルシヤフト | 置換ｎ−アリールピラゾールの製造方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH652389A5 (en) * | 1982-02-03 | 1985-11-15 | Sandoz Ag | Process for the preparation of o,o'-disubstituted phenylhydrazines |
| US4599403A (en) * | 1985-10-07 | 1986-07-08 | Harold Levy | Method for recovery of stevioside |
| YU46200A (sh) * | 1998-02-27 | 2003-02-28 | Pfizer Products Inc. | N-(supstituisani peto-članog di-ili triaza dinezasićenog prstena)karbonil/guanidin derivati za tretiranje ishemije |
-
2001
- 2001-10-31 MX MXPA03004783A patent/MXPA03004783A/es unknown
- 2001-10-31 CA CA002430061A patent/CA2430061A1/en not_active Abandoned
- 2001-10-31 JP JP2002546503A patent/JP2004514706A/ja active Pending
- 2001-10-31 EP EP01978750A patent/EP1337508A1/en not_active Withdrawn
- 2001-10-31 AU AU2002210839A patent/AU2002210839A1/en not_active Abandoned
- 2001-10-31 WO PCT/IB2001/002052 patent/WO2002044133A1/en not_active Application Discontinuation
- 2001-10-31 BR BR0115616-0A patent/BR0115616A/pt not_active IP Right Cessation
- 2001-11-26 AR ARP010105485A patent/AR035601A1/es unknown
- 2001-11-27 US US09/995,133 patent/US6753334B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2430061A1 (en) | 2002-06-06 |
| EP1337508A1 (en) | 2003-08-27 |
| AR035601A1 (es) | 2004-06-16 |
| BR0115616A (pt) | 2003-09-16 |
| US20020082274A1 (en) | 2002-06-27 |
| WO2002044133A1 (en) | 2002-06-06 |
| US6753334B2 (en) | 2004-06-22 |
| JP2004514706A (ja) | 2004-05-20 |
| MXPA03004783A (es) | 2003-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002213485A1 (en) | Inhibitors of protein kinases | |
| AU2001258771A1 (en) | -secretase inhibitors | |
| GB0025782D0 (en) | Use of inhibitors | |
| AU2001241927A1 (en) | Inhibitors of p38-alpha kinase | |
| AU2001237041A1 (en) | Kinase inhibitors | |
| PL362691A1 (en) | Bacterial gyrase inhibitors and uses thereof | |
| SI1686119T1 (sl) | Derivati pirimidin-5-ona kot inhibitorji ldl-pla2 | |
| AU2001240542A1 (en) | Heterocyclic compounds and their use as parp inhibitors | |
| AU2001234484A1 (en) | Amide compounds for inhibiting protein kinases | |
| AU2001258784A1 (en) | Tyrosine phosphatase inhibitors | |
| SI1251848T1 (en) | Gyrase inhibitors and uses thereof | |
| AU4882101A (en) | Mmp-12 inhibitors | |
| AU2001244355A1 (en) | Heterobiarylsulphonamides and their use as pde 7 inhibitors | |
| HUP0300061A3 (en) | Use of il-18 inhibitors | |
| AU2001236052A1 (en) | Urease inhibitors | |
| AU2002222627A1 (en) | Tak1 inhibitors | |
| AU2002210839A1 (en) | Preparation of sodium-hydrogen exchanger type-1 inhibitors | |
| AU2001255090A1 (en) | Cdk inhibitors having 3-hydroxychromen-4-one structure | |
| AU2002224550A1 (en) | Corrosion inhibitors | |
| AU2001232809A1 (en) | Gyrase inhibitors and uses thereof | |
| GB2370093B (en) | Axially compliant isolator | |
| AU2002214038A1 (en) | Inhibitors of transglutaminases | |
| AU5029801A (en) | Copolymers of allylphosphonium salts | |
| AU2001266124A1 (en) | 2-aminothiazoline derivatives and their use as no-synthase inhibitors | |
| AU2002224835A1 (en) | Dihydroisoquinolines as novel phosphodiesterase inhibitors |